Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Channel Technologies Group was a U.S.-based engineered materials and component manufacturer best known for piezoelectric ceramics, transducers, sonar systems, sensors, and integrated systems used across defense, medical device, energy, and industrial markets. In healthcare, its products were enabling components for medical instruments such as electrosurgical, RF ablation, phacoemulsification, laparoscopic, and therapeutic ultrasonic devices rather than proprietary therapeutic drug programs. The company originated in 1959 as Channel Industries and later operated from Santa Barbara, California, with additional manufacturing operations in Illinois and other historical locations. Channel Technologies was recapitalized by Blue Wolf Capital Partners in 2012, and in 2017 its ceramics division assets were acquired by Piezo Kinetics. Based on the available evidence, it should be classified primarily as an industrial/medical device component company rather than a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Channel Technologies Group.